FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2220977678> ?p ?o ?g. }

• W2220977678 endingPage "22" @default.
• W2220977678 startingPage "6313" @default.
• W2220977678 abstract "A 61-year-old woman was diagnosed in June 2011 as having immunoglobulin G (IgG) ĸ-type multiple myeloma (MM), stage II, according to the International Staging System (ISS). Chromosome analysis showed a complex karyotype, including t(11;14) and del 13q. Analysis of the cell surface markers revealed that the cells were positive for mature plasma cell-1 (MPC-1), and negative for cluster of differentiation (CD) 45 and CD49e, suggestive of an intermediate level of maturity of the cells. The disease was refractory to bortezomib-dexamethasone (BD) therapy and progressed to plasma cell leukemia despite the treatment. Treatment was therefore switched to lenalidomide-dexamethasone (RD) therapy, however, the condition again proved to be refractory to this therapy. A partial response (PR) was achieved with vincristine-doxorubicin-dexamethasone (VAD) therapy. The residual plasma cells became CD45-positive, suggesting a change of the cells from an intermediate level of maturity to mature cells. In December, autologous peripheral blood stem cell transplantation (Auto-PBSCT) was performed after high-dose melphalan therapy (melphalan 200 mg/m(2)) as pretreatment. PR was observed and a second Auto-PBSCT was performed in July 2012. Stringent complete remission (sCR) has been maintained for 2 years since, without any further treatment. This is the first reported case of secondary plasma cell leukemia (sPCL) resistant to new drugs that was successfully treated by high-dose melphalan in combination with VAD therapy and Auto-PBSCT." @default.
• W2220977678 created "2016-06-24" @default.
• W2220977678 creator A5010010620 @default.
• W2220977678 creator A5031116384 @default.
• W2220977678 creator A5032625498 @default.
• W2220977678 creator A5045687594 @default.
• W2220977678 creator A5048908270 @default.
• W2220977678 creator A5050568825 @default.
• W2220977678 creator A5055784289 @default.
• W2220977678 creator A5062556988 @default.
• W2220977678 creator A5065998049 @default.
• W2220977678 creator A5066764468 @default.
• W2220977678 creator A5074397578 @default.
• W2220977678 date "2014-01-01" @default.
• W2220977678 modified "2023-10-14" @default.
• W2220977678 title "A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation." @default.
• W2220977678 cites W1508201389 @default.
• W2220977678 cites W1529714767 @default.
• W2220977678 cites W1966423882 @default.
• W2220977678 cites W1967025604 @default.
• W2220977678 cites W1978930370 @default.
• W2220977678 cites W1992984993 @default.
• W2220977678 cites W2003426156 @default.
• W2220977678 cites W2029070213 @default.
• W2220977678 cites W2039581172 @default.
• W2220977678 cites W2042264019 @default.
• W2220977678 cites W2046933119 @default.
• W2220977678 cites W2055744416 @default.
• W2220977678 cites W2062483499 @default.
• W2220977678 cites W2066138044 @default.
• W2220977678 cites W2066671330 @default.
• W2220977678 cites W2066800926 @default.
• W2220977678 cites W2082169216 @default.
• W2220977678 cites W2103282571 @default.
• W2220977678 cites W2121464444 @default.
• W2220977678 cites W2163783953 @default.
• W2220977678 cites W2164807675 @default.
• W2220977678 cites W2166587891 @default.
• W2220977678 cites W2052581929 @default.
• W2220977678 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4203256" @default.
• W2220977678 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25337285" @default.
• W2220977678 hasPublicationYear "2014" @default.
• W2220977678 type Work @default.
• W2220977678 sameAs 2220977678 @default.
• W2220977678 citedByCount "3" @default.
• W2220977678 countsByYear W22209776782017 @default.
• W2220977678 countsByYear W22209776782018 @default.
• W2220977678 countsByYear W22209776782019 @default.
• W2220977678 crossrefType "journal-article" @default.
• W2220977678 hasAuthorship W2220977678A5010010620 @default.
• W2220977678 hasAuthorship W2220977678A5031116384 @default.
• W2220977678 hasAuthorship W2220977678A5032625498 @default.
• W2220977678 hasAuthorship W2220977678A5045687594 @default.
• W2220977678 hasAuthorship W2220977678A5048908270 @default.
• W2220977678 hasAuthorship W2220977678A5050568825 @default.
• W2220977678 hasAuthorship W2220977678A5055784289 @default.
• W2220977678 hasAuthorship W2220977678A5062556988 @default.
• W2220977678 hasAuthorship W2220977678A5065998049 @default.
• W2220977678 hasAuthorship W2220977678A5066764468 @default.
• W2220977678 hasAuthorship W2220977678A5074397578 @default.
• W2220977678 hasConcept C126322002 @default.
• W2220977678 hasConcept C143998085 @default.
• W2220977678 hasConcept C2776063141 @default.
• W2220977678 hasConcept C2776364478 @default.
• W2220977678 hasConcept C2776396001 @default.
• W2220977678 hasConcept C2776694085 @default.
• W2220977678 hasConcept C2776755627 @default.
• W2220977678 hasConcept C2777408962 @default.
• W2220977678 hasConcept C2777478702 @default.
• W2220977678 hasConcept C2778283404 @default.
• W2220977678 hasConcept C2778461978 @default.
• W2220977678 hasConcept C2778684742 @default.
• W2220977678 hasConcept C2779429289 @default.
• W2220977678 hasConcept C2779823535 @default.
• W2220977678 hasConcept C2780353925 @default.
• W2220977678 hasConcept C2780401358 @default.
• W2220977678 hasConcept C28328180 @default.
• W2220977678 hasConcept C2911091166 @default.
• W2220977678 hasConcept C54355233 @default.
• W2220977678 hasConcept C71924100 @default.
• W2220977678 hasConcept C86803240 @default.
• W2220977678 hasConcept C90924648 @default.
• W2220977678 hasConceptScore W2220977678C126322002 @default.
• W2220977678 hasConceptScore W2220977678C143998085 @default.
• W2220977678 hasConceptScore W2220977678C2776063141 @default.
• W2220977678 hasConceptScore W2220977678C2776364478 @default.
• W2220977678 hasConceptScore W2220977678C2776396001 @default.
• W2220977678 hasConceptScore W2220977678C2776694085 @default.
• W2220977678 hasConceptScore W2220977678C2776755627 @default.
• W2220977678 hasConceptScore W2220977678C2777408962 @default.
• W2220977678 hasConceptScore W2220977678C2777478702 @default.
• W2220977678 hasConceptScore W2220977678C2778283404 @default.
• W2220977678 hasConceptScore W2220977678C2778461978 @default.
• W2220977678 hasConceptScore W2220977678C2778684742 @default.
• W2220977678 hasConceptScore W2220977678C2779429289 @default.
• W2220977678 hasConceptScore W2220977678C2779823535 @default.
• W2220977678 hasConceptScore W2220977678C2780353925 @default.
• W2220977678 hasConceptScore W2220977678C2780401358 @default.

• next